Concepedia

Publication | Closed Access

[Establishment of a cisplatin-resistant human ovarian cancer cell line].

36

Citations

0

References

1993

Year

Hidenori Sasa, A Hisano, Kenji Ishii, J Hirata, Yasushi Kikuchi, Ichiro Nagata, Akira Senoo, Shuji Aida, S Tamai, Michio Sugita
PubMed

Abstract

A human ovarian cancer cell line designated "MH" was established from ascites of a patient with ovarian serous cystadenocarcinoma treated with cisplatin. This cell line was grown for more than 2 years and over 100 passages in medium RPMI1640 containing 10% FCS. The cell doubling time, saturation density and plating efficiency was approximately 6.3 days, 5.5 x 10(4)/cm2, and 42%, respectively. Chromosomal analysis revealed aneuploidy with a modal number of 72 and 14-19 types of marker chromosomes. CA125 was detected in both the original tumor and the cultured cells. This cell line is cisplatin-resistant (IC50: 3.28 microM) and has high protein kinase C activity.